Literature DB >> 20786144

Penicillin Therapy in Acute Bacterial Endocarditis.

A Dolphin, R Cruickshank.   

Abstract

Entities:  

Year:  1945        PMID： 20786144      PMCID： PMC2057771          DOI： 10.1136/bmj.1.4408.897

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  The Prognosis and Treatment of Staphylococcal Septicaemia.

Authors:  N W McLellan; A Goldbloom
Journal:  Can Med Assoc J       Date:  1942-02       Impact factor: 8.262
  1 in total
  7 in total

1.  [Not Available].

Authors:  G B ROEMER
Journal:  Klin Wochenschr       Date:  1948-08-01

2.  [On the occurrence of B streptococci in man].

Authors:  G Kexel
Journal:  Z Hyg Infektionskr       Date:  1965-12-01

3.  Streptococcus agalactiae (group B) endocarditis--a description of twelve cases and review of the literature.

Authors:  B E Scully; D Spriggs; H C Neu
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

Review 4.  Neonatal streptococcal infections.

Authors:  M T Parker
Journal:  Postgrad Med J       Date:  1977-10       Impact factor: 2.401

5.  Observations and comments concerning the isolation of group B beta-hemolytic streptococci from human sources.

Authors:  P D Finn; F A Holden
Journal:  Can Med Assoc J       Date:  1970-08-01       Impact factor: 8.262

6.  Antibiotics in management of staphylococcal endocarditis; with special reference to increasing bacterial resistance.

Authors:  D C LEVINSON; G C GRIFFITH; H E PEARSON
Journal:  Calif Med       Date:  1951-03

7.  Beta-Hemolytic Streptococcal Infective Endocarditis: Characteristics and Outcomes From a Large, Multinational Cohort.

Authors:  Núria Fernández Hidalgo; Amal A Gharamti; María Luisa Aznar; Benito Almirante; Mohamad Yasmin; Claudio Querido Fortes; Patrick Plesiat; Thanh Doco-Lecompte; Hussein Rizk; Dannah Wray; Cristiane Lamas; Emanuele Durante-Mangoni; Pierre Tattevin; Ulrika Snygg-Martin; Margaret M Hannan; Vivian H Chu; Zeina A Kanafani
Journal:  Open Forum Infect Dis       Date:  2020-04-10       Impact factor: 3.835
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.